Trade Associations
Here's a look at documents from national and international trade associations
Featured Stories
Clean Fuels Alliance America: New Study Finds California's Soybean ILUC Values Are Outdated
JEFFERSON CITY, Missouri, Dec. 6 (TNSrpt) -- Clean Fuels Alliance America issued the following news release:
* * *
New Study Finds California's Soybean ILUC Values Are Outdated
A recent study commissioned by Clean Fuels Alliance America and Farmers Fueling the Future finds that California's indirect land use change (ILUC) assumptions for U.S. soy-based biodiesel and renewable diesel are outdated lacking modern agricultural practices and current science.
The analysis, Land Use Change Emissions Associated with Soybeans: Considerations for California's LCFS, conducted by Life Cycle Associates
... Show Full Article
JEFFERSON CITY, Missouri, Dec. 6 (TNSrpt) -- Clean Fuels Alliance America issued the following news release:
* * *
New Study Finds California's Soybean ILUC Values Are Outdated
A recent study commissioned by Clean Fuels Alliance America and Farmers Fueling the Future finds that California's indirect land use change (ILUC) assumptions for U.S. soy-based biodiesel and renewable diesel are outdated lacking modern agricultural practices and current science.
The analysis, Land Use Change Emissions Associated with Soybeans: Considerations for California's LCFS, conducted by Life Cycle Associates(LCA), highlights substantially lower ILUC emissions for soy-based fuels than those currently used by the California Air Resources Board (CARB). Considerations include advances in economic modeling, land-use data, yield responsiveness, trade patterns and carbon stock measurements.
CARB last updated its soybean ILUC value in 2018 using modeling tools and data that predate many of today's improvements in agricultural productivity and global market dynamics. The latest research shows ILUC values well below CARB's current assumptions calculated with more recent global data through updated GTAP modeling.
According to the report, improvements in modeling and data inputs have consistently reduced estimated ILUC emissions for soy-based biodiesel and renewable diesel, producing results that better align with observed land-use and market behavior.
"This study confirms that today's farmers are meeting growing clean fuel demand through higher yields and responsible practices--not land expansion," said Dave Walton, Executive Board Member for Clean Fuels and the American Soybean Association. "CARB must modernize its approach and base its values on today's science to accurately recognize the real carbon benefits of soy-based biodiesel and renewable diesel."
According to Clean Fuels, the findings underscore the need for California's Low Carbon Fuel Standard to reflect current data and real-world agricultural performance as the state works to decarbonize its transportation sector.
The full study is available on cleanfuels.org.
* * *
About Farmers Fueling the Future
Farmers Fueling the Future is a biofuel research initiative between the American Soybean Association and the Iowa Soybean Association.
* * *
ABOUT CLEAN FUELS ALLIANCE AMERICA
Made from an increasingly diverse mix of resources such as recycled cooking oil, soybean oil, and animal fats, the clean fuels industry is a proven, integral part of America's clean energy future. Clean Fuels Alliance America is the U.S. trade association representing the entire biodiesel, renewable diesel and sustainable aviation fuel supply chain, including producers, feedstock suppliers and fuel distributors. Clean Fuels receives funding from a broad mix of private companies and associations, including the United Soybean Board and state checkoff organizations.
* * *
REPORT: https://cleanfuels.org/wp-content/uploads/LCA_Soy-iLUC-2025_FINAL.pdf
* * *
Original text here: https://cleanfuels.org/new-study-finds-californias-soybean-iluc-values-are-outdated/
[Category: Energy]
NABIP Statement on GAO Findings Regarding APTC Fraud
WASHINGTON, Dec. 6 -- The National Association of Benefits and Insurance Professionals (formerly the National Association of Health Underwriters) issued the following news release:
* * *
NABIP Statement on GAO Findings Regarding APTC Fraud
The National Association of Benefits and Insurance Professionals (NABIP) is alarmed by the Government Accountability Office's (GAO) latest findings showing that serious fraud vulnerabilities in the Advance Premium Tax Credit (APTC) program continue, putting federal subsidy dollars, program integrity, and consumers at risk.
GAO's preliminary testing shows
... Show Full Article
WASHINGTON, Dec. 6 -- The National Association of Benefits and Insurance Professionals (formerly the National Association of Health Underwriters) issued the following news release:
* * *
NABIP Statement on GAO Findings Regarding APTC Fraud
The National Association of Benefits and Insurance Professionals (NABIP) is alarmed by the Government Accountability Office's (GAO) latest findings showing that serious fraud vulnerabilities in the Advance Premium Tax Credit (APTC) program continue, putting federal subsidy dollars, program integrity, and consumers at risk.
GAO's preliminary testing showsfictitious applicants were able to obtain subsidized federal Marketplace coverage in plan years 2024 and 2025, highlighting weaknesses in the eligibility and identity checks that drive APTC payments.
These concerns reflect issues NABIP has repeatedly raised with federal agencies. In our comment letters to CMS and HHS, we urged them to strengthen APTC safeguards through rapid multi-factor authentication across Healthcare.gov, Direct Enrollment, and Enhanced Direct Enrollment, tighter Special Enrollment Period verification, stronger National Producer Number standards, and faster, more transparent investigations that remove bad actors quickly.
"NABIP members help individuals and families access affordable coverage the right way, and this report makes clear CMS must update its APTC fraud risk assessment and strengthen real-time controls," said Jessica Brooks-Woods, CEO of NABIP. "We support aggressive action to stop bad actors and protect federal APTC dollars, Marketplace program integrity, and the consumers we serve, but reforms must be targeted so they don't restrict legitimate consumer help or penalize ethical agents and brokers."
NABIP and its members are actively meeting with members of Congress to discuss extending the tax credits beyond 2025 and to press for strong, common-sense fraud protections in the federal Marketplace. "Honest brokers and agents are harmed by bad actors, and so are the clients and communities we serve," Brooks-Woods added. "Fraud and unauthorized enrollments erode consumer trust, destabilize the risk pool, and create real-world consequences for individuals and families who depend on this subsidized coverage."
To advance enrollment integrity, NABIP will soon launch the Certified Integrity Broker(TM) (CIB) designation. This national standard focuses on ethical conduct, identity protection, consent verification, fraud-prevention training, and public accountability through an Integrity Registry and annual recertification.
NABIP stands ready to work with GAO, CMS, and Congress to reinforce APTC program integrity and protect consumers from fraud and unauthorized activity in the federal Marketplace. Ensuring Marketplace safeguards are strong must go hand in hand with keeping coverage affordable. With enhanced APTC improvements scheduled to expire at the end of 2025, NABIP urges Congress to extend these subsidies so millions of Americans are not hit with steep premium increases or forced to forgo coverage.
We also encourage policymakers to align these efforts with NABIP's Healthcare Bill of Rights, which affirms every consumer's right to accurate information, informed consent, and access to trusted, licensed professional guidance.
* * *
NABIP is the preeminent organization for health insurance and employee benefits professionals, working diligently to ensure all Americans have access to high-quality, affordable healthcare and related benefits. NABIP represents more than 100,000 licensed health insurance agents, brokers, general agents, consultants and benefit professionals through more than 150 chapters.
* * *
Original text here: https://nabip.org/media/10709/gao-report_aptc-fraud_v2.pdf
[Category: Insurance]
National MS Society: New Study Underscores Importance of Knowing How Medications Affect Cognition
NEW YORK, Dec. 6 -- The National Multiple Sclerosis Society issued the following news:
* * *
New Study Underscores Importance of Knowing How Medications Affect Cognition
Medications showed both positive and negative effects on cognition in a study of 260 people with MS. Carefully assessing medications is important to individualizing treatment and preventing the adverse effects of taking multiple medications.
Lead author Dr. Jeeyeon Kim (University of Michigan) is funded by the National MS Society through a Mentor-Based Postdoctoral Fellowship in Rehabilitation Research award to coauthor Dr.
... Show Full Article
NEW YORK, Dec. 6 -- The National Multiple Sclerosis Society issued the following news:
* * *
New Study Underscores Importance of Knowing How Medications Affect Cognition
Medications showed both positive and negative effects on cognition in a study of 260 people with MS. Carefully assessing medications is important to individualizing treatment and preventing the adverse effects of taking multiple medications.
Lead author Dr. Jeeyeon Kim (University of Michigan) is funded by the National MS Society through a Mentor-Based Postdoctoral Fellowship in Rehabilitation Research award to coauthor Dr.Anna Kratz.
Background: Research shows that polypharmacy - taking 5 or more medications - is an under-recognized problem among people with MS. In addition to MS disease-modifying therapies, people with MS might be taking medications to address symptoms. When multiple medications are taken at the same time, there may be unexpected and harmful health effects.
Cognitive changes occur in as many as one half of people with MS. This team of researchers from the Universities of Michigan and Washington sought to determine how certain medications might contribute to these changes.
The Study: The researchers evaluated medication usage and cognition among 260 people with MS enrolled in the CogDetect-MS Study. This ongoing study follows people with MS to determine what predicts cognitive problems, and what effects they have on social and physical function in MS.
Participants reported all the medications they were using. Researchers assessed cognitive function using objective measures and subjective reports from participants.
Results: People enrolled in this study used an average of 6.5 medications. Nearly 63% of participants were using 5 or more. Most (69.2%) used DMTs. The most common symptom medications were antidepressants, followed by non-opioid painkillers and antispasmodics. The least used were corticosteroids and opioids.
Several connections were made between medication usage and cognitive function. For example, opioid use was linked to poorer executive functions (skills that enable you to plan, organize, and complete goals).
Antidepressant use was linked to faster processing speed, and corticosteroid use was linked to increased memory, including the ability to hold onto new information and retrieve older information.
Why does this matter? People with MS can experience a variety of symptoms with the disease. Research is increasingly indicating polypharmacy among people with MS, which can increase the risk of adverse effects, includingincreased falls, cognitive problems, fatigue. and hospitalization. Studies like these can help people with MS and their providers to ensure that medications are prescribed individually and thoughtfully.
Learn more...
Get tips for managing multiple medications
Learn more about assessing and managing your cognitive health
"Associations between medication use and multiple domains of cognitive function in people with multiple Sclerosis" by Jeeyeon Kim, Keara M. Ginell, Serena Marecle, Cory Wernimont, Tiffany J. Braley, Dawn M. Ehde, Kevin N. Alschuler, Nora E. Fritz, Anna L. Kratz, is published in MS & Related Disorders (2026;105:106854).
* * *
About Multiple Sclerosis
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.
About the National Multiple Sclerosis Society
The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalmssociety.org, Facebook, X (formerly known as Twitter), Instagram, YouTube or 1-800-344-4867.
* * *
Original text here: https://www.nationalmssociety.org/news-and-magazine/news/research-breaking-news-5
[Category: Health Care]
Infectious Diseases Society: ACIP - Statement on Changes to HBV Birth Dose Vaccine Recommendation
ARLINGTON, Virginia, Dec. 6 -- The Infectious Diseases Society of America issued the following statement on Dec. 5, 2025:
* * *
ACIP: Statement on Changes to HBV Birth Dose Vaccine Recommendation
The American Association for the Study of Liver Diseases (AASLD) and its undersigned partner organizations - the American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE), the Infectious Diseases Society of America (IDSA), and the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition
... Show Full Article
ARLINGTON, Virginia, Dec. 6 -- The Infectious Diseases Society of America issued the following statement on Dec. 5, 2025:
* * *
ACIP: Statement on Changes to HBV Birth Dose Vaccine Recommendation
The American Association for the Study of Liver Diseases (AASLD) and its undersigned partner organizations - the American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE), the Infectious Diseases Society of America (IDSA), and the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition(NASPGHAN) - are alarmed by the 8-3 vote by the Advisory Committee on Immunization Practices (ACIP) to abandon the recommendation to initiate universal hepatitis B vaccination immediately after birth. Relying on the hepatitis B status of the infant's mother to determine whether the birth dose is appropriate creates confusion and ambiguity for new parents, the community, and medical professionals when the evidence clearly supports the safety and effectiveness in providing lifetime protection of administering a universal birth dose after consultation between an infant's parents and their health care provider.
As the leading societies dedicated to prevention, treatment and cure of liver diseases, we continue to strongly recommend that the hepatitis B vaccine be administered at birth to all infants as part of the validated three dose schedule rather than delaying the first dose to two months for confirmed hepatitis B negative mothers and for the full vaccination series to be administered to all infants. We call on the Centers for Medicare & Medicaid Services to ensure that coverage for the birth dose without cost sharing remains in place and that states take steps to ensure access for all who choose the vaccine.
Eliminating the universal birth dose recommendation will end a public health practice that has prevented 95% of new hepatitis B infections and an estimated 90,100 deaths in the United States. Relying on hepatitis B screening of pregnant women will not be as effective as universal vaccination. Despite a recommendation for universal screening of pregnant women for hepatitis B, up to 16% of pregnant women (more than 575,000 American newborns at risk each year) were not screened annually between 2015-2019. Should ACIP's revised recommendation be implemented, this screening gap will result in preventable chronic hepatitis B infections which lead to the development of cirrhosis, liver failure, and liver cancer.
Administering the hepatitis B vaccine within the first 24 hours of birth is the safest way to prevent perinatal transmission and protect infants and young children from horizontal transmission. According to the Centers for Disease Control and Prevention's (CDC) data, approximately 90% of infants and 30% of children between ages 1-5 years exposed to hepatitis B will develop chronic hepatitis B compared to only 5% of adults. Research has shown that horizontal transmission, which can occur in daycare or through routine contact with caregivers or family members unaware of their status, carries around a 40% chance of infection. The birth dose closes critical gaps in maternal screening, documentation errors, missed opportunities for prevention, and the growing number of births occurring outside traditional hospital settings. While all infants should return for their well child visits, this does not always occur, and delaying the first dose for some infants will inevitably increase the number of infants who remain unvaccinated.
The policy change will disproportionately affect communities already carrying the highest burden of hepatitis B, including Asian American, Pacific Islander, and African communities, as well as infants born in settings with inconsistent documentation or limited prenatal care. It also will undermine the commitment of the Department of Health and Human Services and the CDC - that we share - to eliminate viral hepatitis by 2030 as outlined in the Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025. We urge the CDC to reconsider this decision and reaffirm the universal birth dose as an essential component of comprehensive hepatitis B prevention. The evidence is unequivocal: universal birth dose vaccination saves lives, prevents chronic liver disease and liver cancer, and strengthens the nation's public health infrastructure.
Our organizations stand by the universal birth dose recommendation, which already provides for consultation between parents and health care providers, and will work with clinicians, community partners, families, and policymakers to ensure every infant in the United States continues to be protected from a lifelong, preventable liver disease.
* * *
Original text here: https://www.idsociety.org/news--publications-new/articles/2025/acip-statement-on-changes-to-hbv-birth-dose-vaccine-recommendation/
[Category: Medical]
American College of Cardiology Supports Front of Package Nutrition Labeling
WASHINGTON, Dec. 6 -- The American College of Cardiology posted the following news release:
* * *
American College of Cardiology Supports Front of Package Nutrition Labeling
Easy to understand nutrition labels on front of food can help consumers make heart healthy choices
*
Simplifying nutrition information can empower consumers to make healthier, more informed dietary choices and reduce their risk of cardiovascular disease (CVD), according to guidance issued by the American College of Cardiology and published in JACC, its flagship journal. The new guidance supports a standardized front-of-packaging
... Show Full Article
WASHINGTON, Dec. 6 -- The American College of Cardiology posted the following news release:
* * *
American College of Cardiology Supports Front of Package Nutrition Labeling
Easy to understand nutrition labels on front of food can help consumers make heart healthy choices
*
Simplifying nutrition information can empower consumers to make healthier, more informed dietary choices and reduce their risk of cardiovascular disease (CVD), according to guidance issued by the American College of Cardiology and published in JACC, its flagship journal. The new guidance supports a standardized front-of-packagingfood labeling system that highlights key nutrients to limit or encourage.
Diet-related chronic diseases are the leading causes of death and disability in the United States, disproportionately affecting individuals from certain racial and ethnic groups and those of lower socioeconomic status. Following healthy dietary patterns, including a low intake of saturated fat, cholesterol, sodium and added sugars, is associated with a reduced risk of obesity, CVD, Type 2 diabetes and several types of cancer. Conversely, diets rich in whole grains, fruits, vegetables, fiber and unsaturated fats are associated with lower morbidity and mortality.
"Nutrition is foundational to cardiovascular health; however, the overabundance of food choices and inconsistent messaging have created confusion among the public," said Kim Allan Williams, MD, MACC, chair of the writing committee and chair of the University of Louisville Department of Medicine. "Front of package labeling presents an opportunity to translate nutrition science into real-world consumer guidance and provide a rapid, visual cue at the point of purchase that highlights nutrients most relevant to chronic disease risk like saturated fat, sodium and added sugars."
In January 2025, the FDA proposed a new nutrition info label for the front of food packages that highlights the percentage of saturated fat, sodium and added sugars per serving, plus classifies each as high, medium or low. Currently, nutrition facts are typically located on the back or side of a food package and provide detailed information on calorie content, macronutrients, micronutrients and ingredients per serving.
Front of package labels would complement current Nutrition Facts, not replace them. The labels would use illustrations, symbols and systems that are easy to understand, helping consumers convey useful nutrition-related information to make healthier dietary choices. One commonly used method for front of package labels is the "Traffic Light Approach," which uses the colors red, yellow and green to indicate whether a product contains high, medium or low amounts of fats, sugar or sodium. This color-coded approach is thought to assist less health-conscious and nutrition-minded individuals in understanding nutritional values and increase the reach of nutrition education.
The ACC guidance outlines the rationale for supporting FDA-led front of package labeling as a transparent, science-based policy that prioritizes public health and offers clear direction to food manufacturers. The document reviews evidence on the effectiveness of front of package labeling in 44 other countries and highlights key considerations for implementation in the U.S.
The guidance also serves as a flowchart to guide clinician-patient conversations about healthy eating. The 2019 ACC/AHA Primary Prevention of Cardiovascular Disease Guideline recommends a plant-forward diet high in fruits, vegetables, whole grains, nuts, legumes and fish with avoidance of processed meats, refined carbohydrates and trans fats; however, clinicians receive limited formal training in nutrition and often do not adhere to these guidelines themselves.
"The average clinician spends less than three minutes on nutrition counseling during a patient visit," Williams said. "The front of package labeling can serve as bridge during these conversations by providing nutrition education at the point of decision-making and guide clinician/patient conversations about heart-healthy food choices."
Nutrition and Front-of-Package Food Labeling as a Catalyst for Cardiovascular Health: 2025 ACC Concise Clinical Guidance will be available in JACC on Dec. 5, 2025, at 10 am ET. For an embargoed copy, contact Olivia Walther at owalther@acc.org.
* * *
The American College of Cardiology (ACC) is a global leader dedicated to transforming cardiovascular care and improving heart health for all. For more than 75 years, the ACC has empowered a community of over 60,000 cardiovascular professionals across more than 140 countries with cutting-edge education and advocacy, rigorous professional credentials, and trusted clinical guidance. From its world-class JACC Journals and NCDR registries to its Accreditation Services, global network of Chapters and Sections, and CardioSmart patient initiatives, the College is committed to creating a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or connect on social media at @ACCinTouch.
The ACC's JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) -- and specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure -- pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.
* * *
Original text here: https://www.acc.org/About-ACC/Press-Releases/2025/12/05/18/22/American-College-of-Cardiology-Supports-Front-of-Package-Nutrition-Labeling
[Category: Medical]
APhA Voices Concern Over Hepatitis B Recommendation Change
WASHINGTON, Dec. 6 -- The American Pharmacists Association issued the following news release on Dec. 5, 2025:
* * *
APhA voices concern over hepatitis B recommendation change
The American Pharmacists Association (APhA) is deeply disappointed by today's vote by the CDC's Advisory Committee on Immunization Practices (ACIP) to remove the universal recommendation for administering the hepatitis B vaccine birth dose for infants born in the United States. This reversal rolls back a highly effective, evidence-based public health measure that has been in place since 1991.
Since the universal birth-dose
... Show Full Article
WASHINGTON, Dec. 6 -- The American Pharmacists Association issued the following news release on Dec. 5, 2025:
* * *
APhA voices concern over hepatitis B recommendation change
The American Pharmacists Association (APhA) is deeply disappointed by today's vote by the CDC's Advisory Committee on Immunization Practices (ACIP) to remove the universal recommendation for administering the hepatitis B vaccine birth dose for infants born in the United States. This reversal rolls back a highly effective, evidence-based public health measure that has been in place since 1991.
Since the universal birth-doserecommendation was adopted, acute hepatitis B virus (HBV) infections in infants and young children have sharply decreased, preventing countless children from becoming chronic carriers. The hepatitis B vaccine is safe, effective, and the most reliable method to prevent chronic HBV infection. Infants born to mothers who are not HBV carriers remain at risk due to possible exposure from infected household members, caregivers, human bites, or shared personal items such as toothbrushes--making universal vaccination essential.
"Pharmacists have a long history of helping to prevent disease transmission through vaccine recommendation and administration, including against hepatitis B," said Brigid Groves, PharmD, MS, vice president of professional affairs at APhA. "We remain steadfast in our commitment to protecting patients across their lifespan. The science is clear: the hepatitis B birth dose saves lives, and there is no new evidence to justify delaying or removing this critical protection."
Newborns infected with HBV have a 90% likelihood of becoming chronic carriers, and one in four infants infected at birth will die from HBV-related liver failure or liver cancer. Young children who contract HBV face a 20% to 50% chance of developing lifelong chronic infection. These severe outcomes--and the costly, intensive treatment they require--are preventable through timely vaccination.
APhA strongly supports preserving the integrity of the established, evidence-based childhood immunization schedule, including the HepB birth dose that has consistently proven safe and effective.
APhA also underscores the importance of hepatitis B vaccination in adulthood. ACIP continues to recommend the vaccine series for all adults ages 19-59 years, adults 60 years and older with risk factors, and any adult who requests vaccination. Hepatitis B vaccines are safe, effective, and covered by insurance.
We will continue to advocate for evidence-based immunization policies and the health and safety of patients and communities nationwide.
* * *
About APhA
APhA is the only organization advancing the entire pharmacy profession. From our headquarters in Washington, DC, APhA leads the pharmacy profession by supporting pharmacists, student pharmacists, and pharmacy technicians in their role optimizing medication use and patient health outcomes and ensuring patients have access to pharmacists' care. We do this through our strong and effective advocacy, top notch education, practice tools and resources, dissemination of evidence, and opportunities for members to engage and learn from each other. APhA is the pharmacy voice at the table in developing national guidelines, policies, and best practices that advance the profession and patient care. To learn more, visit www.pharmacist.com.
* * *
Original text here: https://www.pharmacist.com/APhA-Press-Releases/apha-voices-concern-over-hepatitis-b-recommendation-change
[Category: Medical]
ALPA Canada Pilots Make Their Case on Parliament Hill
MCLEAN, Virginia, Dec. 6 -- The Air Line Pilots Association International issued the following news release on Dec. 4, 2025:
* * *
ALPA Canada Pilots Make Their Case on Parliament Hill
OTTAWA, Ont.--ALPA Canada leadership was joined this week by elected ALPA representatives from across Canada to speak with Members of Parliament and Senators on Parliament Hill. The topics of discussion focused on flight- and duty-time (FT/DT) issues and the impact of governmental interference in the collective bargaining process.
ALPA Canada continues to advocate for continued discussion and collaboration on
... Show Full Article
MCLEAN, Virginia, Dec. 6 -- The Air Line Pilots Association International issued the following news release on Dec. 4, 2025:
* * *
ALPA Canada Pilots Make Their Case on Parliament Hill
OTTAWA, Ont.--ALPA Canada leadership was joined this week by elected ALPA representatives from across Canada to speak with Members of Parliament and Senators on Parliament Hill. The topics of discussion focused on flight- and duty-time (FT/DT) issues and the impact of governmental interference in the collective bargaining process.
ALPA Canada continues to advocate for continued discussion and collaboration onthe effectiveness of the current regulations and whether they effectively mitigate fatigue, enhance safety, and meet their original intent.
"ALPA Canada opposes any attempt to weaken or suspend FT/DT regulations, which are fundamentally safety regulations," said Capt. Tim Perry, ALPA Canada president. "We believe there is a need for increased collaboration with government and aviation stakeholders to collectively enhance safety standards."
ALPA Canada is also calling for the implementation of a more transparent and inclusive policy-making process to ensure that all relevant parties, including ALPA Canada, have the opportunity to contribute to discussions and decisions regarding aviation policy and regulations.
Regarding free and fair collective bargaining, ALPA Canada has witnessed, over the past two years, a worrying trend of the Canadian government forcing outcomes at the bargaining table, thereby playing into underhanded employer tactics by asking the Canada Industrial Relations Board to settlethe outstanding terms of the collective agreements between employers and workers, while imposing final binding arbitration.
"ALPA Canada believes it is always in the best interests of both sides to negotiate contracts in good faith at the negotiating table," Capt. Perry continued. "When parties are directed to bargain in good faith and remain at the bargaining table to put in the hard work required, a better outcome is often reached for all sides involved."
ALPA remains committed to working with the government and other aviation stakeholders to ensure Canadians have the safest and most robust aviation industry possible.
Founded in 1931, ALPA is the largest airline pilot union in the world and represents more than 80,000 pilots at 43 U.S. and Canadian airlines. Visit ALPA.org or follow us on Twitter @ALPAPilots.
* * *
Original text here: https://www.alpa.org/Press-Room/2025/12/ALPA-Canada-Pilots-Make-Their-Case-on-Parliament-Hill
[Category: Transportation]
